Previous close | 2.8700 |
Open | 3.2000 |
Bid | 2.5600 |
Ask | 2.7900 |
Strike | 75.00 |
Expiry date | 2025-01-17 |
Day's range | 2.8700 - 3.2000 |
Contract range | N/A |
Volume | |
Open interest | 588 |
AstraZeneca ( LON:AZN ) Second Quarter 2024 Results Key Financial Results Revenue: US$12.9b (up 13% from 2Q 2023). Net...
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.
The United Kingdom's stock market has recently experienced declines, influenced by disappointing trade data from China and its broader economic challenges. Amidst these market conditions, identifying undervalued stocks can offer investors potential opportunities for value in a landscape marked by global uncertainties. In this environment, a good stock may be characterized by robust fundamentals such as strong balance sheets and consistent earnings, which provide resilience against ongoing...